Ulonivirine

• UNSPSC Description:

  Ulonivirine (MK-8507) is an orally active non-nucleoside reverse transcriptase inhibitor with high antiviral activity. Ulonivirine can be used for the research of HIV-1 infection[1].

• Target Antigen:

  HIV; Reverse Transcriptase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/ulonivirine.html

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  N#CC1=CC(Cl)=CC(OC2=C(C(F)(F)F)N=CN(CC3=NNC(C(C(F)(F)F)=C3)=O)C2=O)=C1

• Molecular Weight:

  491.73

• References & Citations:

  [1]Schürmann D, et al. Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week. J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):191-198.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  Phase 2

• CAS Number:

  1591823-76-5